89 related articles for article (PubMed ID: 1963812)
21. Cancer chemopreventive activity of rotenoids from Derris trifoliata.
Ito C; Itoigawa M; Kojima N; Tan HT; Takayasu J; Tokuda H; Nishino H; Furukawa H
Planta Med; 2004 Jun; 70(6):585-8. PubMed ID: 15229812
[TBL] [Abstract][Full Text] [Related]
22. Cancer chemopreventive agents (antitumor-promoters) from Ajuga decumbens.
Takasaki M; Tokuda H; Nishino H; Konoshima T
J Nat Prod; 1999 Jul; 62(7):972-5. PubMed ID: 10425119
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effects of lantadenes and related triterpenoids on Epstein-Barr virus activation.
Inada A; Nakanishi T; Tokuda H; Nishino H; Iwashima A; Sharma OP
Planta Med; 1995 Dec; 61(6):558-9. PubMed ID: 8824951
[TBL] [Abstract][Full Text] [Related]
24. Identification of pheophorbide a and its related compounds as possible anti-tumor promoters in the leaves of Neptunia oleracea.
Nakamura Y; Murakami A; Koshimizu K; Ohigashi H
Biosci Biotechnol Biochem; 1996 Jun; 60(6):1028-30. PubMed ID: 8695903
[TBL] [Abstract][Full Text] [Related]
25. Correlation with redox potentials and inhibitory effects on Epstein-Barr virus activation of azaanthraquinones.
Koyama J; Morita I; Tagahara K; Osakai T; Hotta H; Yang MX; Mukainaka T; Nishino H; Tokuda H
Chem Pharm Bull (Tokyo); 2001 Sep; 49(9):1214-6. PubMed ID: 11558617
[TBL] [Abstract][Full Text] [Related]
26. Screening of tissue cultures and thalli of lichens and some of their active constituents for inhibition of tumor promoter-induced Epstein-Barr virus activation.
Yamamoto Y; Miura Y; Kinoshita Y; Higuchi M; Yamada Y; Murakami A; Ohigashi H; Koshimizu K
Chem Pharm Bull (Tokyo); 1995 Aug; 43(8):1388-90. PubMed ID: 7553984
[TBL] [Abstract][Full Text] [Related]
27. Cucurbitane triterpenoids from the leaves of Momordica charantia, and their cancer chemopreventive effects and cytotoxicities.
Zhang J; Huang Y; Kikuchi T; Tokuda H; Suzuki N; Inafuku K; Miura M; Motohashi S; Suzuki T; Akihisa T
Chem Biodivers; 2012 Feb; 9(2):428-40. PubMed ID: 22344919
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of iridoids on Epstein-Barr virus activation by a short-term in vitro assay for anti-tumor promoters.
Kapadia GJ; Sharma SC; Tokuda H; Nishino H; Ueda S
Cancer Lett; 1996 Apr; 102(1-2):223-6. PubMed ID: 8603374
[TBL] [Abstract][Full Text] [Related]
29. Cancer preventive agents. Part 8: Chemopreventive effects of stevioside and related compounds.
Takasaki M; Konoshima T; Kozuka M; Tokuda H; Takayasu J; Nishino H; Miyakoshi M; Mizutani K; Lee KH
Bioorg Med Chem; 2009 Jan; 17(2):600-5. PubMed ID: 19131254
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of chemical Epstein-Barr virus induction by dimethyl sulfoxide and related polar compounds.
Yanase S; Sugawara K
Intervirology; 1989; 30(3):163-8. PubMed ID: 2546900
[TBL] [Abstract][Full Text] [Related]
31. Two new anti-tumor promoting serratane-type triterpenoids from the stem bark of Picea jezoensis var. jezoensis.
Tanaka R; Ishikawa Y; Minami T; Minoura K; Tokuda H; Matsunaga S
Planta Med; 2003 Nov; 69(11):1041-7. PubMed ID: 14735444
[TBL] [Abstract][Full Text] [Related]
32. Potential anti-tumor promoting activity of lupane-type triterpenoids from the stem bark of Glochidion zeylanicum and Phyllanthus flexuosus.
Tanaka R; Kinouchi Y; Wada S; Tokuda H
Planta Med; 2004 Dec; 70(12):1234-6. PubMed ID: 15643564
[TBL] [Abstract][Full Text] [Related]
33. Correlation between reduction potentials and inhibitory effects on Epstein-Barr virus activation of poly-substituted anthraquinones.
Koyama J; Morita I; Kobayashi N; Osakai T; Nishino H; Tokuda H
Cancer Lett; 2005 Jul; 225(2):193-8. PubMed ID: 15978323
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effects of 3-O-acyl-(+)-catechins on Epstein-Barr virus activation.
Uesato S; Taniuchi K; Kumagai A; Nagaoka Y; Seto R; Hara Y; Tokuda H; Nishino H
Chem Pharm Bull (Tokyo); 2003 Dec; 51(12):1448-50. PubMed ID: 14646330
[TBL] [Abstract][Full Text] [Related]
35. Correlation between reduction potentials and inhibitory effects on Epstein-Barr virus activation by emodin derivatives.
Koyama J; Inoue M; Morita I; Kobayashi N; Osakai T; Nishino H; Tokuda H
Cancer Lett; 2006 Sep; 241(2):263-7. PubMed ID: 16338070
[TBL] [Abstract][Full Text] [Related]
36. [Inhibitory effect of retinoids on Epstein-Barr virus induction in Raji cells].
Zeng Y; Zhou HM; Xu JP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Aug; 4(4):251-3. PubMed ID: 6295650
[No Abstract] [Full Text] [Related]
37. Synthesis of novel polyphenols consisted of ferulic and gallic acids, and their inhibitory effects on phorbol ester-induced Epstein-Barr virus activation and superoxide generation.
Nomura E; Hosoda A; Morishita H; Murakami A; Koshimizu K; Ohigashi H; Taniguchi H
Bioorg Med Chem; 2002 Apr; 10(4):1069-75. PubMed ID: 11836117
[TBL] [Abstract][Full Text] [Related]
38. Bendamustine reactivates latent Epstein-Barr virus.
Fernandez SG; Miranda JJ
Leuk Lymphoma; 2016 May; 57(5):1208-10. PubMed ID: 26371746
[No Abstract] [Full Text] [Related]
39. Correlation of redox potentials and inhibitory effects on Epstein-Barr virus activation of naphthoquinones.
Koyama J; Morita I; Kobayashi N; Osakai T; Hotta H; Takayasu J; Nishino H; Tokuda H
Cancer Lett; 2003 Nov; 201(1):25-30. PubMed ID: 14580683
[TBL] [Abstract][Full Text] [Related]
40. Differential inhibitory effects of retinoic acid on Epstein-Barr virus induction in producer and nonproducer cell lines.
Morigaki T; Sugawara K; Ito Y
Intervirology; 1984; 22(1):56-60. PubMed ID: 6329997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
